CLYM
Climb BioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
CLYM Profile
Climb Bio, Inc.
A clinical-stage biotechnology company developing treatments for patients with immune-mediated diseases
20 William Street, Suite 145, Wellesley Hills, MA 02481
--
Climb Bio, Inc., was incorporated as a Delaware corporation on October 18, 2018. The company is a biotechnology company focused on developing novel therapies for neuronal excitatory disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and peripheral and central nervous system diseases.
